Keyphrases
Influenza
100%
Mouse Model
100%
Neuraminidase
100%
Control Disease
100%
A(H1N1)pdm09
40%
Monoclonal Antibody
30%
Neuraminidase Inhibitors
30%
Antiviral Activity
30%
Influenza Virus
20%
Lethal Challenge
20%
H5N1 Influenza Virus
20%
Balb C Mice
20%
Broad Protection
20%
Virus
10%
Public Health
10%
Specific Antibodies
10%
Disease Severity
10%
Vietnam
10%
Viral
10%
Therapeutic Approaches
10%
Novel Therapeutics
10%
H1N1
10%
Hemagglutinin
10%
Influenza A
10%
Plaque Size
10%
H5N1
10%
Novel Vaccines
10%
Associated Diseases
10%
Correlates of Protection
10%
Glutamic Acid
10%
Carboxyl Terminus
10%
Binding Activity
10%
Antigenic Properties
10%
Linear Epitope
10%
H1N1 Virus
10%
Viral Neuraminidase
10%
H5N1 Virus
10%
Specific Monoclonal Antibodies
10%
Size Reduction
10%
Conformational Epitope
10%
Protection Potential
10%
Vaccine Approaches
10%
Inhibition Activity
10%
Human Challenge Studies
10%
Influenza Human
10%
Hemagglutinin Antibodies
10%
NA Inhibition
10%
Heterosubtypic Protection
10%
Protective Epitope
10%
Influenza Neuraminidase
10%
Cross-protective
10%
Next-generation Vaccines
10%
Acid Residue
10%
Immunology and Microbiology
Monospecific Antibody
100%
Influenza
100%
Mouse Model
100%
Monoclonal Antibody
50%
Influenza A Virus (H5N1)
50%
Antiviral Activity
37%
Vaccine Efficacy
25%
Influenza A Virus (H1N1)
25%
Bagg Albino Mouse
25%
Hemagglutinin
12%
Influenzavirus A
12%
Antigenicity
12%
Linear Epitope
12%
Viral Neuraminidase
12%
Epitope
12%
Influenza Virus
12%
Binding Affinity
12%
Carboxy Terminal Sequence
12%
Virus Hemagglutinin
12%
Conformational Epitope
12%